41
Participants
Start Date
September 1, 2020
Primary Completion Date
September 1, 2021
Study Completion Date
September 1, 2021
Intralesional Triamcinolone 5 mg/ml
Solution containing 5 mg TAC was injected intralesionally, every week for 6 weeks or until the scar flattened, whichever occurred earlier. Not more than 2 ml of the solution was injected per session, using 27G needle pre-mounted on an insulin syringe.
Intralesional 5-fluorouracil
Solution containing 45 mg 5-FU was injected intralesionally, every week for 6 weeks or until the scar flattened, whichever occurred earlier. Not more than 2 ml of the solution was injected per session, using 27G needle pre-mounted on an insulin syringe.
Maharajgunj Medical Campus, Institute of Medicine, Kathmandu
Maharajgunj Medical Campus
OTHER